Nash, Kevin R <br/><br/>
Fractalkine over expression suppresses α-synuclein-mediated neurodegeneration.  [electronic resource] 

 -  Molecular therapy : the journal of the American Society of Gene Therapy  Jan 2015 
 - 17-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-0024 
<br/><br/><label>Standard No.: </label>10.1038/mt.2014.175  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine<br/>Animals<br/>Antigen Presentation<br/>Astrocytes--metabolism<br/>Chemokine CX3CL1--agonists<br/>Dependovirus--genetics<br/>Gene Expression Regulation<br/>Genetic Therapy--methods<br/>Genetic Vectors<br/>Glial Fibrillary Acidic Protein<br/>Histocompatibility Antigens Class II--genetics<br/>Male<br/>Mice<br/>Microglia--metabolism<br/>Nerve Tissue Proteins--genetics<br/>Neurons--metabolism<br/>Oxidopamine<br/>Parkinson Disease, Secondary--chemically induced<br/>Parkinsonian Disorders--genetics<br/>Promoter Regions, Genetic<br/>Rats<br/>Signal Transduction<br/>Substantia Nigra--metabolism<br/>Tyrosine 3-Monooxygenase--genetics<br/>alpha-Synuclein--antagonists & inhibitors